Eli Lilly and Company (NYSE:LLY) is recommended as one of the best long-term low volatility stocks to buy. J.P. Morgan maintains a Buy rating on LLY. The Phase 3 monarchE trial shows a 15.8% reduction in the risk of death with Verzenio plus ET for early breast cancer. Results published in the Annals of Oncology and submitted to regulatory authorities worldwide. LLY develops and sells pharmaceutical products in various therapeutic areas. No promotional content included.

Read more at Yahoo Finance: Why is Eli Lilly and Company (LLY) One of the Best Long Term Low Volatility Stocks to Buy Right Now?